27 C
Imphal
More

    India’s Panacea Biotec To Make 100 Million Sputnik Vaccine Doses Yearly: Report



    The Russian Direct Investment Fund did not say when production would begin.

    Moscow:

    Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia’s Sputnik V COVID-19 vaccine annually, the Russian Direct Investment Fund (RDIF), which markets the shot internationally, said on Monday.

    RDIF did not say when production would begin.

    (Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)




    Source link

    - Advertisement -

    More articles

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    - Advertisement -

    Latest article